Drug Interactions between cholera vaccine and ponesimod
This report displays the potential drug interactions for the following 2 drugs:
- cholera vaccine
- ponesimod
Interactions between your drugs
cholera vaccine ponesimod
Applies to: cholera vaccine and ponesimod
ADJUST DOSING INTERVAL: The administration of inactivated, killed, or otherwise noninfectious vaccines during ponesimod therapy is generally safe but may be associated with a diminished or suboptimal immunologic response. Vaccination may be less effective during and for up to one to two weeks after discontinuation of ponesimod therapy.
MANAGEMENT: Immune response to vaccines may be reduced during and for up to one to two weeks after discontinuation of ponesimod therapy. Treatment with ponesimod should be paused 1 week prior to and for 4 weeks after a planned vaccination to allow the full effect of vaccination to occur.
References
- (2021) "Product Information. Ponvory (ponesimod)." Janssen Pharmaceuticals
Drug and food interactions
cholera vaccine food
Applies to: cholera vaccine
ADJUST DOSING INTERVAL: Coadministration of oral cholera vaccine with food or an oral beverage may impair its efficacy. The formulations of both the inactivated and live, attenuated oral cholera vaccines (Dukoral and Vaxchora, respectively) are acid-labile, and must be administered with a buffer. According to the manufacturer, eating and drinking may interfere with the protective effect of the buffer. However, clinical data are not available.
MANAGEMENT: It is recommended that patients avoid eating or drinking for 60 minutes before and after administration of either Dukoral or Vaxchora oral cholera vaccines.
References
- (2023) "Product Information. Vaxchora (cholera vaccine, live)." Patientric Ltd
- (2022) "Product Information. Dukoral (vibrio cholerae vaccine)." Valneva Sweden AB
- (2023) "Product Information. Dukoral (cholera vaccine)." Valneva UK Ltd
- (2024) "Product Information. Vaxchora (cholera vaccine, live)." Emergent Travel Health, Inc
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
See also
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
Check Interactions
To view an interaction report containing 4 (or more) medications, please sign in or create an account.
Save Interactions List
Sign in to your account to save this drug interaction list.